Molecular Characteristics of T Cell-Mediated Tumor Killing in Hepatocellular Carcinoma

BACKGROUND: Although checkpoint blockade is a promising approach for the treatment of hepatocellular carcinoma (HCC), subsets of patients expected to show a response have not been established. As T cell-mediated tumor killing (TTK) is the fundamental principle of immune checkpoint inhibitor therapy,...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Wei-feng, Liu, Mou-yuan, Liang, Li, Zhang, Yang, Li, Zong-juan, Han, Keqi, Du, Shi-suo, Chen, Yan-jie, Ma, Li-heng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100886/
https://www.ncbi.nlm.nih.gov/pubmed/35572523
http://dx.doi.org/10.3389/fimmu.2022.868480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100886/
https://www.ncbi.nlm.nih.gov/pubmed/35572523
http://dx.doi.org/10.3389/fimmu.2022.868480

Ejemplares similares